Britannia Pharmaceuticals

Britannia Pharmaceuticals logo

Founded in 1982, Britannia Pharmaceuticals Limited is a UK based pharmaceutical company specialising in the neurology market.

Our primary expertise is in the development and marketing of products in the area of Parkinson's disease. Active for over 30 years with neurologists and geriatricians, we identified the benefit of and need for apomorphine as a treatment for People with Parkinson's disease, leading to the development of our APO-go© products.

Additionally we have developed non-opiate based therapeutics to assist in opiate detoxification and withdrawal, and have made advances in the areas of wound healing and respiratory disorders.

Contact Britannia Pharmaceuticals via their website

News archive

15/05/2019   Britannia marks World Parkinson’s Day...more

11/04/2019   Britannia supports Mental Health Awareness by holding ‘Wellbeing Week’...more

07/02/2019   Britannia Continues Charity Partnership with SANE...more

08/11/2016   Meet Britannia Pharmaceuticals In Vancouver And Amsterdam During June 2017...more
02/08/2016   Meet Britannia Pharmaceuticals at the 4th World Parkinson Congress...more
07/04/2016   Britannia Pharmaceuticals joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code